Memoplant pills 40 mg 30 pcs
Condition: New product
1000 Items
Rating:
Be the first to write a review!
More info
Active ingredients
Ginkgo bilobate leaf extract
Release form
Pills
Composition
Active ingredient: Ginkgo Biloba; Excipients: lactose monohydrate, colloidal silicon dioxide, microcrystalline cellulose, corn starch, croscarmellose sodium, magnesium stearate; Active ingredient concentration (mg): 40 mg
Pharmacological effect
Angioprotective drug of plant origin. Increases the body's resistance to hypoxia, especially brain tissue. It inhibits the development of traumatic or toxic brain edema. It improves cerebral and peripheral blood circulation, improves the rheological properties of blood.
Pharmacokinetics
The action of the drug Memoplant is the cumulative effect of the components of the extract of the leaves of ginkgo biloba, therefore, conducting kinetic studies is not possible.
Indications
• Disorders of the brain, including age-related, associated with impaired cerebral circulation, accompanied by the following symptoms: memory impairment, decreased ability to concentrate and mental abilities, dizziness, tinnitus, headache .; • Peripheral circulatory disorders: obliterating diseases of the arteries of the lower extremities with such characteristic symptoms as intermittent claudication, numbness and cooling of the feet, Raynaud's disease .; • Dysfunction of the inner ear, manifested by dizziness, unstable gait and tinnitus.
Contraindications
Hypersensitivity to the components of the drug, reduced blood clotting, erosive gastritis, peptic ulcer and duodenal ulcer in the acute stage; acute disorders of cerebral circulation; acute myocardial infarction; children's age up to 12 years - 40 mg, up to 18 years - 80 mg and 120 mg, due to the lack of data on the use of the drug in this age group .; The preparation contains lactose, and therefore it is not recommended to prescribe it to patients with congenital galactosemia, glucose or malabsorption malabsorption syndrome, or in congenital lactase deficiency .; The use of the drug during pregnancy and lactation; Due to the lack of sufficient clinical data, the use of the drug during the period is not recommended.pregnancy and breastfeeding.
Use during pregnancy and lactation
In connection with the lack of sufficient clinical data, it is not recommended to use the drug Memoplant during pregnancy and lactation.
Dosage and administration
If a different dosage regimen is not prescribed by a doctor, the following recommendations for administering Memoplant should be followed: For symptomatic treatment of cerebral circulatory disorders: 40 mg - 1-2 pills 3 times a day. The duration of the course of treatment is at least 8 weeks .; 80 mg - 1 tablet 2-3 times a day. The duration of the course of treatment is at least 8 weeks .; 120 mg 1 tablet 1-2 times a day. The duration of the course of treatment is at least 8 weeks .; For disorders of peripheral circulation: 40 mg - 1 tablet 3 times a day. Duration of treatment - at least 6 weeks .; 80 mg - 1 tablet 2 times a day. Duration of treatment - at least 6 weeks .; 120 mg 1 tablet per day. The duration of the course of treatment is at least 8 weeks .; With vascular or involutional pathology: 40 mg - 1 tablet 3 times a day. Duration of treatment - 6-8 weeks.; 80 mg - 1 tablet 2 times a day. Duration of treatment - 6-8 weeks.; 120 mg 1 tablet per day. Duration of treatment - 6-8 weeks.; After treatment for 3 months, in the absence of results, the appropriateness of further treatment should be checked. Tablets, coated, should be taken inside without chewing, washing down with a small amount of liquid, irrespective of food intake .; If the drug was missed or insufficient quantity was taken, its subsequent administration should be carried out as indicated in this manual without any changes.
Side effects
Allergic reactions (redness, swelling of the skin, itching), in rare cases gastrointestinal disorders (nausea, vomiting, diarrhea), headache, decreased blood clotting, hearing loss, dizziness are possible .; There were isolated cases of bleeding in patients who were simultaneously taking means to reduce blood clotting; causal relationship of these bleeding with taking Ginkgo bilobacter EGb 761; not confirmed. In the event of any adverse events, taking the drug should be discontinued and consult your doctor.
Overdose
To date, no cases of an overdose of Memoplant have been reported. Memoplant has good tolerability.
Interaction with other drugs
The use of Metoplant in patients who are constantly taking acetylsalicylic acid, anticoagulants (direct and indirect action), as well as drugs that reduce blood clotting is not recommended .; It is not recommended to use ginkgo biloba with efavirenz at the same time. It is possible to decrease its plasma concentration due to induction of CYP3A4 under the influence of ginkgo biloba.
special instructions
The patient should be informed that with frequent sensations of dizziness and tinnitus, it is necessary to consult a doctor. In case of sudden deterioration or loss of hearing, you should immediately consult a doctor. Against the background of the use of ginkgo biloped preparations in patients suffering from epilepsy, epileptic seizures may occur .; Impact on the ability to drive vehicles and control mechanisms; During the period of use of the drug, care should be taken when performing hazardous activities that require increased concentration of attention and speed of psychomotor reactions (driving, working with moving mechanisms).